American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its HIV Functional Cure automated cell processing protocol. This completes a key milestone of AGT’s planned Phase I clinical trial of AGT103-T, a genetically modified autologous T cell product in development as an HIV functional cure.
Join BioBuzz and sponsor BioIT Solutions in Rockville at Bar Louie on February 13th, 2018 from 5 – 7pm. Only a 5 minute walk from the Rockville Metro, please join us for this exciting event. BioIT Solutions offers a range of services from enterprise systems built on their 1Platform4® Suite for advanced computational, workflow, and data management systems to IT strategy, architecture and management consulting. The 1Platform4® Suite consists of a software foundation on which various highly configurable modules are assembled and tailored to each client’s specifications and needs.
Northrop Grumman will form a new business sector focused on new, innovative technology once it closes on its acquisition of Orbital ATK this year, a top Northrop executive said during a Thursday earnings call.
Innovators Magazine asked some biotech stakeholders what trends they expect to see in their markets this year.
The opinions were published in our special biotechnology edition, which was distributed to delegates at an industry conference in Glasgow this week.
AOL co-founder Steve Case will be the inaugural speaker for Anchor Ventures’s speaker series. Anchor Ventures is a collaboration between University of Maryland Ventures and Johns Hopkins Technology Ventures.
Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization with proven expertise in gene therapy and next-generation vaccines, is expanding a new process development and cGMP manufacturing facility located conveniently near Baltimore/Washington International Thurgood Marshall (BWI) Airport in Baltimore, Maryland.
2017 marked continued growth for Rockville Economic Development, Inc. (REDI) and the Maryland Women’s Business Center (MWBC).
We are pleased to highlight our many accomplishments in the 2017 Annual Report, which was released today.
Cambridge’s up and coming life sciences firms will be able to benefit from the expertise of some of the biggest names in the sector at a new bio-incubator and life science accelerator.
The pharmaceutical industry continues to pursue the discovery of medicines for cancer patients with unprecedented rigor. Over the past several years, three major trends have reflected this pursuit. They include the growth of the industry pipeline of cancer-drug candidates, the evolution of the clinical-trial landscape, and the explosion of available clinical and real-world data
Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces today the promotion of key personnel and the addition of two industry veterans to its leadership team. Specifically, the Company appoints Philip Wills, PhD, as Chief Commercial Officer, John Conner as Chief Manufacturing Officer, and William “Bill” Thomas, Jr., PhD, as Chief Scientific Officer, and hires Randy Henrickson as VP of Manufacturing and Dermot McCaul as VP of Information Technology.
